Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 20,183 | 19,363 | 18,218 | 16,837 | 8,244 |
| Cost of Goods | 4,617 | 3,834 | 6,512 | 4,415 | 4,055 |
| Gross Profit | 15,566 | 15,529 | 11,706 | 12,422 | 4,189 |
| Operating Expenses | 12,811 | 24,039 | 30,065 | 96,961 | 171,045 |
| Operating Income | 3,372 | -7,676 | -17,847 | -84,124 | -166,801 |
| Other Income | -2,979 | -1,184 | 70,843 | 7,470 | -38,374 |
| Pre-tax Income | 393 | -8,860 | 52,996 | -76,654 | -205,175 |
| Income Tax | 2 | N/A | 17 | 44 | 17 |
| Net Income Continuous | 391 | -8,860 | 52,979 | -76,698 | -205,192 |
| Net Income | $391 | $-8,860 | $52,979 | $-76,698 | $-205,192 |
| EPS Basic Total Ops | 0.00 | -0.11 | 10.36 | -167.42 | -2,953.75 |
| EPS Basic Continuous Ops | 0.00 | -0.11 | 10.98 | -164.60 | -2,938.95 |
| EPS Diluted Total Ops | 0.00 | -0.11 | 0.05 | -167.42 | -2,953.75 |
| EPS Diluted Continuous Ops | 0.00 | -0.11 | 0.05 | -164.60 | -2,938.95 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.12 | 0.05 | -167.50 | -2,604.95 |
| EBITDA(a) | $3,998 | $-6,920 | $-17,370 | $-83,109 | $-165,778 |